** Shares of GSK GSK.L up 4.5% at 1,442p - top pct gainer on the FTSE 100 index .FTSE
** The British drugmaker lifts 2031 sales target to more than 40 bln pounds from the 38 bln pounds previously expected
** Co beats Q4 earnings with core EPS of 23.2p vs IBES ests of 19.01p, on strength in its HIV and oncology portfolio
** Reports Q4 sales of 8.12 bln pounds ($10.15 bln), above IBES ests of 7.75 bln pounds
** Launches share buyback of 2 bln pounds
** Sets 2025 sales growth target of 3%-5% against analysts' expectations for growth of about 3.5%, according to a company-compiled consensus
** GSK fell about 12% in the last 12 months
($1 = 0.8002 pounds)
(Reporting by Yamini Kalia in Bengaluru)
((Yamini.Kalia@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.